Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study (Q45737816)

15 December 2017

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study (English)

1 reference

15 December 2017

1 reference

1 reference

6

1 reference

15 December 2017

F Imbert-Bismut

1

1 reference

15 December 2017

V Ratziu

2

1 reference

15 December 2017

L Pieroni

3

1 reference

15 December 2017

F Charlotte

4

1 reference

15 December 2017

Y Benhamou

5

1 reference

15 December 2017

MULTIVIRC Group

7

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

15 December 2017

1 reference

15 December 2017

357

1 reference

15 December 2017

1069-1075

1 reference

15 December 2017

9262

1 reference

Fibrosis in patients with chronic hepatitis C: detection and significance

15 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Appropriateness of liver biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Alpha-2-macroglobulin and hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Noninvasive diagnosis of hepatic fibrosis or cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Albumin standards and the measurement of serum albumin with bromcresol green

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Transforming growth factor-beta-induced collagen synthesis by human liver myofibroblasts is inhibited by alpha2-macroglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Cell swelling increased the alpha2-macroglobulin gene expression in cultured rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Rat hepatic stellate cell expression of alpha2-macroglobulin is a feature of cellular activation: implications for matrix remodelling in hepatic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Haptoglobin polymorphism and chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

The hepatocyte growth factor regulates the synthesis of acute-phase proteins in human hepatocytes: Divergent effect on interleukin-6-stimulated genes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Cytokines and the hepatic acute phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Modulation of gamma-glutamyltranspeptidase in normal rat hepatocytes in culture by cell density, epidermal growth factor and agents which alter cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Studies on the relationship between the histological changes and liver cell function or plasma proteins in hepatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904258-6

7 January 2021

10.1016/S0140-6736(00)04258-6

Identifiers

DOI

1 reference

15 December 2017

1 reference